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Introduction
Transplantation of transgenic organs or tissue between widely disparate species as the ultimate solution for donor shortage shows promising results [1] . However, many aspects of rejection are still unknown, as evidenced by the muddle of immunosuppressive drugs that are needed to keep pig organs functional. Using small animals, the guinea-pig (GP)-to-rat rodent model provides an easy and fast way to study the basics of discordant transplantation. The recipient produces pre-formed xenoreactive natural antibodies (XNAs) against the GP, which are capable of rejecting heart grafts in a hyperacute manner [2] . XNAs are mainly IgM type [3] , but some donorspeci®c IgG antibodies have been detected [4] .
For allogeneic grafting, the relative insensitivity of liver grafts to antibody-mediated rejection has been described [5, 6] . In a previous publication, we investigated whether this phenomenon also occurred in the GP-to-rat liver transplantation model [7] . We demonstrated that a`rejected' GP liver was not characterized by the classical features of hyperacute rejection (HAR) [7] . However, recipients died within a few days, apparently because of non-immunological reasons. Therefore, no ®rm conclusions could be drawn regarding susceptibility of discordant liver graft toward antibody-mediated rejection [7] . Numerous studies have reported long-term survival of hamster grafts, indicating no interference of non-immunological problems in this model [8± 10] . However, the rat has very low titers of preformed antibodies to hamster. To mimic a discordant situation with pre-formed IgM or IgG antibodies, we sensitized recipients with donor blood at 1 or 5 weeks before transplantation.
Hence, the aim of the current study was to analyze the mechanism of HAR of liver xenografts in the presence of pre-formed antibodies and to compare this with the rejection of heart xenografts.
Materials and methods

Animals
Female Syrian hamsters were used as donors and male Brown Norway rats as recipients. All animals were obtained from Harlan CPB (Austerlitz, The Netherlands). They were kept under controlled laboratory conditions and received food and tap water ad libitum. Hamsters weighing over 120 g and rats weighing between 250 and 300 g were used. The experimental protocols adhered to the rules laid down in the Dutch Animal Experimentation Act (1977) and the published Guidelines on the Protection of Experimental Animals by the Council of the EC (1986). The speci®c protocol was approved by thè Committee on Animal Research' of the Erasmus University Rotterdam, The Netherlands.
Liver transplantation
Orthotopic liver transplantation (OLT) was performed according to a previously described method with some donor-related modi®cations [7, 11] . The modi®cations were (1) donor pretreatment with 0.1 mg/kg atropine (Centrafarm Services, Etten-Leur, The Netherlands), and (2) the outside diameters of the Te¯on cuffs were 2.1 mm and 1.79 mm for the IVC and PV respectively. Recipient death was taken as the end point of rejection.
Heart transplantation
Heterotopic abdominal heart transplantation (HTx) was performed as described by Ono and Lindsey [12] . Cessation of heartbeat as evidenced by abdominal palpation was taken as the end point of rejection.
Sensitization
Hamster blood was obtained by orbital punction. One milliliter of heparinized blood was injected i.v. into the penile vein of the recipient 1 or 5 weeks before organ grafting.
Hemagglutination assay
Total antibody and IgG levels were measured using a hemagglutination assay. Plasma samples, taken immediately before grafting, were serially diluted. A suspension of freshly prepared hamster erythrocytes (4%) was added in equal amounts. After 1 h of incubation at 37 uC, the wells were screened for agglutination. The dilution at which agglutination still occurred was considered the hemagglutination titer. For IgG level measurements, plasma samples were treated with 0.5 mM dithiothreitol for half an hour at 37 uC to deplete IgM. Normal BN serum was taken as negative control. Estimations of IgM titers were calculated by subtracting IgG titers from total antibody titers.
Histology and immunohistochemistry
After rejection of the grafts, necropsy was performed. The heart graft or upper liver lobe was removed and processed for histology and immunohistochemistry. Paraf®n sections were stained with hematoxylin±eosine and examined with conventional light microscopy. The slides were examined for extravasation, edema, vessel damage and in®ltration. Changes were noted compared with naive grafts and scored from ± (no changes) to +++ (severe changes)
For antibody, complement depositions and natural killer (NK) cell in®ltration, immunohistochemistry on frozen sections was performed. Macrophages were identi®ed on paraf®n sections. FITC-labeled mouse anti-rat antibodies to demonstrate IgM, IgG1, IgG2a and IgG2b were used (1:10; PharMingen, San Diego CA, USA). IgG2c and complement C3 were demonstrated by FITC-conjugated rabbit anti-sheep (1:100; Dako, Glostrup, Denmark) to sheep anti-rat antibodies (1:500; ANAWA Trading NA, Wangen Zurich, Switzerland). Complement factors C1q and C9 were stained by rabbit anti-rat IgG (1:25, 1:600, respectively, kindly provided by Dr B. P. Morgan) and secondary FITC-labeled swine anti-rabbit (Dako). Rat spleen was taken as positive control, whereas liver and heart from naive hamsters were used as negative controls. The slides were analyzed by¯uorescence microscopy. Location of the depositions was noted and the¯uorescence intensity was scored from ± (no depositions) to +++ (massive depositions). A three-step indirect Ni-DAB immunoperoxidase staining was performed on paraf®n slides to demonstrate macrophage in®ltration. Mouse anti-rat macrophage was used as primary antibody (ED1, 1:800; Serotec, Oxford, UK). Staining was performed with Ni±DAB substrate after the application of rabbit anti-mouse PO and swine anti-rabbit PO antibodies (1:250; Dako). Applying the same protocol, NK cells were demonstrated on frozen sections using mouse anti-rat NK cells (NKR±P1, 1:400; Endogen, Woburn MA, USA). Conventional light microscopy was used to analyze the in®ltration.
Experimental design
Heart and liver transplantations were carried out in different recipients. Sensitization with 1 ml of hamster blood was performed 1 week before transplantation (1-week sensitized) in groups 2 and 5 and 5 weeks before transplantation (5-week sensitized) in groups 3 and 6. Groups 2 and 3 received heart grafts (n = 5 for both); groups 5 and 6 obtained liver grafts (n = 7 and n = 5 respectively). Non-sensitized control groups were included for both heart (group 1, n = 7) and liver transplantations (group 4, n = 8). On day 0 the recipients obtained a heterotopic heart graft or orthotopic liver graft. Survival, as determined by abdominal palpation or death, was scored in minutes, hours or days, depending on the treatment. At necropsy the heart graft or upper liver lobe was removed and processed for histology and immunohistochemistry. Heart and liver grafts were semiquantitatively scored for type and quantity of antibody and histologic changes.
Statistics
Statistical evaluation of the survival data was carried out for both heart and liver grafts. In cases of differences in variances as tested by Levene's test, mathematical transformation of the survival data was carried out. This was carried out to reduce the in¯uence of outlying values.`One-way' analysis of variance (ANOVA) was performed on these data. If the ANOVA was signi®cant on a 5% level, the Duncan's multiple comparison test or Games±Howell test was carried out for possible differences among the means. The tests were corrected for the fact that the comparisons were not statistically independent and for unequal group sizes.
Probability values lower than 0.05 were considered statistically signi®cant. Survival of transplants with clear evidence of no rejection (liver enzymes, histology) was discarded from statistical evaluation. All computing was performed using the statistical software package SPSS for Windows, release 7.5.2.
Results
Histology
Specimens of the transplanted organs were obtained for histologic examination after killing the animals at the moment of rejection or death. Heart grafts rejected by non-sensitized rats showed vessel destruction, extravasation, edema and polymorphonuclear cell in®ltrate, suggesting an antibody-mediated rejection. Also, the presence of mononuclear cells was noted. Groups 2 and 3 showed more severe extravasation of erythrocytes, ®brosis and edema. The overall architecture, including most vessels, was intact. In some cases, polymorphonuclear granulocytes were found.
Control liver grafts demonstrated polymorphonuclear in®ltrate, destroyed vascular morphology with destroyed endothelial cell layers, edema, and a more predominant mononuclear cell in®ltrate than heart grafts, consisting of lymphocytes, lymphoblasts, monocytes and macrophages. This indicates a mixture of cellular as well as antibody-mediated rejection. The in®ltrate was situated around the portal areas.
Liver grafts of 1-week sensitized recipients showed extravasation, edema, signs of ®brosis and vascular congestion, but little vessel damage. Focally, mononuclear granulocytes were found. Specimens of liver grafts in group 6 revealed extensive tissue damage, extravasation and acute liver cell damage. Semiquantitative histology scores are listed in Table 1 .
Immunohistochemistry
Frozen sections of heart and liver grafts were stained for IgM, IgG subtypes, complement C1q, C3 and C9, and NK-cell in®ltrates. Paraf®n sections were used to stain for macrophages. All control stainings were positive on untreated rat spleen, whereas untreated hamster liver and heart sections were negative.
Control hearts showed major IgM depositions. Some IgG2a type antibodies and macrophages were noticed. Liver grafts from untreated rat recipients showed minor antibody depositions on cellular in®ltrates or portal ®eld, mainly being IgM. Macrophages, but not NK cells were deposited throughout the tissue.
Heart grafts from 1-week sensitized recipients demonstrated massive antibody depositions, whereas liver grafts demonstrated minor depositions. In groups 3 and 6, moderate IgG1 depositions could be demonstrated. In addition, depositions of IgG2a and IgG2b were detected on myocytes. For liver grafts depositions of IgG2b were found. Semiquantitative antibody deposition scores are listed in Table 2 .
Liver grafts from untreated rat recipients showed some C1q depositions, but no C3 and C9, whereas all measured complement components could be detected on heart grafts. Sensitizing rats 1 week before transplantation resulted in moderate C3 depositions in both heart and liver grafts. In addition, positive Kupffer cells were found. C1q could only be detected in heart grafts, whereas little C9 was found in liver grafts. In 5-week sensitized recipients, massive C3 and moderate C9 depositions were demonstrated for heart grafts. Moderate C3 depositions and to a lesser extent C1q could be shown for liver grafts in group 6.
Graft survival
Heart and liver grafts showed a homogeneous reperfusion after releasing the clamps. After a few minutes, the heart grafts turned dark red. Liver grafts in group 6, but not group 5, were purple and showed swelling 2 min after reperfusion. Most of the recipients of liver grafts died showing the clinical signs of shock.
Graft survival times are shown in Table 3 . A highly signi®cant difference was demonstrated between the group means in the hearttransplanted groups (P = 0.000, s res = 35.730) and between the group means in the livertransplanted groups (P = 0.000, s res = 0.567). Non-sensitized heart graft recipients showed prolonged survival compared with both other heart graft recipients (P , 0.001, both). No difference was found between 1-week-sensitized and 5-week-sensitized animals. The survival times of the non-sensitized group receiving liver grafts were signi®cantly longer than those of animals in groups 5 and 6 (P = 0.000, both). Survival times in groups 5 and 6 were not signi®cantly different, but a trend was noticed (P = 0.081).
IgM and IgG agglutination titers
Hemagglutination tests revealed the presence of speci®c anti-hamster IgM antibodies in 1-weeksensitized animals on day 0. The IgM titer was negligible in recipients sensitized 5 weeks before grafting. Anti-hamster IgG was present in all recipients, albeit considerably higher in recipients sensitized at week ±5. Normal BN serum revealed agglutinating titers of one-quarter or lower. No statistically signi®cant correlation was found between pre-operative antibody titer and survival or histologic changes in either sensitization group. Scores varied from ± (no changes) to +++ (severe changes) compared with naive heart/liver. OLT, non-sensitized
OLT, 5-week-sensitized ± ++ ¡ + ± Scores varied from ± (no depositions) to +++ (massive depositions). . Hamster heart or liver was grafted in BN rat after sensitization to hamster-blood at 1 week (groups 2 and 5) or 5 weeks (groups 3 and 6) before transplantation. In control groups 1 and 4, hamster heart or liver was grafted into naive BN rat. Both control groups were statistically different from their sensitization groups. Survival times of animals that died are in parentheses.
Discussion
The immunoprivileged position of liver grafts to antibody-mediated rejection has been a research subject for many years. Pre-formed antibodies in the circulation of patients before transplantation have been identi®ed as the cause of HAR of allografts [13] . However, hyperacute antibodymediated rejection is not necessarily observed [5, 14] . Liver allografts seem to be less susceptible to antibody-mediated rejection. The phenomenon of reduced susceptibility has been demonstrated in previous studies concerning experimental liver allotransplantation in (sensitized) recipients [6, 15] . In discordant liver grafting, we and others were unable to resolve this question, because the recipients died from nonimmunological problems [7, 16] . For that reason, we performed the current experiments. Similarly, as described by others, we found that nonsensitized controls rejected hearts signi®cantly earlier than liver grafts [10, 17] . Histologically, control heart grafts showed a prominent vascular rejection process, whereas rejected liver grafts (group 4) revealed a more predominant cellular rejection with mononuclear cell in®ltrates. Moreover, antibody depositions of the IgM type were more pronounced on heart grafts than liver grafts. These ®ndings indicate that in the untreated concordant hamster to rat combination the liver might be less affected by IgM. It can be argued that liver grafts are less immunogenic than heart grafts, resulting in a diminished and sluggish antibody response resulting in less damage. However, this is not very plausible, because anti-donor antibody levels peak around days 5±7 for both liver and heart transplantation [18±20]. Moreover, Murase et al. [21] reported that cytotoxic antibody titers after xenogeneic liver grafting are 10 times higher than after heart grafting. Infusion of hamster hepatocytes or non-parenchymal liver cells was able to induce high cytotoxic antibody titer within 1 week, and splenic response to liver grafts is even higher than to cardiac grafts [22, 23] . This indicates that liver grafts may be at least as immunogenic as heart grafts.
Another plausible explanation is that the liver graft protects itself, because the source of complement and the target organ are the same, leading to prolonged survival [24] . This is in accordance with the time required to transform the proteins to donor type pro®le [7, 25] . Nevertheless, residual recipient complement components and neosynthesis, by macrophages, monocytes, and ®broblasts, are still able to cause lysis [24] .
In normal BN serum, hemagglutinating antibodies were almost non-detectable. In the discordant situation, grafted organs encounter high titers of pre-formed antibodies. Immunogenicity is therefore of less relevance than the af®nity of antibodies for the different tissues. To mimic the pre-formed antibody situation, we sensitized rat recipients with hamster antigen in order to evoke an antibody response. This sensitization, 1 or 5 weeks before transplantation, resulted in graft survival of minutes to hours for both liver and heart grafts. The differences found between liver and heart graft survival in the sensitized situation may be explained by the difference in survival readout for the grafts. It is known that rats can live for several hours after total hepatectomy with just a portal caval shunt [7] .
At necropsy, massive antibody depositions could be detected in heart grafts from 1-week sensitized recipients. Extravasation of erythrocytes, edema, ®brosis and vascular congestion, suggesting complement-mediated endothelial damage, indicate an ongoing HAR. Liver grafts from recipients sensitized 1 week before transplantation, however, showed an overall intact morphology and only marginal signs of HAR. This corresponds to their phenotypic appearance after grafting. Yet, classical signs of HAR were noted in liver grafts from 5-week sensitized animals: acute liver cell degradation, extensive tissue damage and extravasation of erythrocytes. Purple recoloration and swelling were noticed after reperfusion. Immunohistochemistry showed IgG depositions, whereas no graft depositions could be found in rats sensitized at week ±1.
Circulating IgM, present 1 week after sensitization, is likely to be deposited on the heart as well as liver grafts. However, the results indicate that liver grafts, in contrast to heart grafts, seem to be less affected by IgM as seen by immunohistochemisty and complement depositions. One possibility is that the liver is releasing blocking agents, preventing antibody deposition, which has been hypothesized by Kamada et al. [26] Another explanation is that graft size difference gives rise to difference in deposition density and therefore rejection. However, a more likely possibility is that Kupffer cells absorb large amounts of lymphocytotoxic antibodies [27, 28] . Moreover, Crafa et al. [29] reported that Kupffer cell activation led to signi®cant reduced circulation of anti-donor antibodies and a more intense IgM uptake after discordant liver grafting as demonstrated by immunohistochemistry. In the present study, however, liver grafts showed minor IgM depositions. Other authors have reported similar ®ndings. Tuso et al. [30] demonstrated that xenogeneic extracorporeal liver perfusion resulted in minimal immunohistochemical evidence of binding of human xenoantibodies. Nevertheless, reduced antibody binding to other organs was found after xenogeneic liver perfusion [30] . Even prolonged heart xenograft survival has been reported after preceding xenogeneic liver transplantation [31] . This indicates that liver grafts, unlike heart grafts, are less susceptible to antibody-mediated damage, probably because of absorption or non-binding of antibodies, possibly IgM.
Five weeks after sensitization, mainly IgG-type antibodies prevail. Histology of rejected livers showed a severe HAR with IgG and complement deposition, which were not detected in the grafts after recipient sensitization at week ±1. It seems therefore that IgG, speci®cally some IgG subtypes, may be responsible for the rejection process in liver grafts. In addition, several authors found that in experimental allogeneic liver transplantation after recipient sensitization graft failure was dependent on the antibody class being IgG [32, 33] . Moreover, IgG, in contrast to IgM, seems to be the most dangerous in clinical allotransplantation across positive cross-matches [34, 35] . The minor damage seen in liver grafts of 1-week sensitization recipients might be caused by the already formed, relatively low titers of IgG.
This could also explain why in discordant grafting no signs of HAR were seen, because most XNAs are of the IgM type [3, 4, 7, 36] .
In conclusion, this study suggests a more dominant role for IgG over IgM antibodies in the rejection of liver xenografts. Such predominance does not exist for heart grafts.
